13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurotoxicology
Neurotoxicology examines the harmful effects that toxic substances have on the nervous system, particularly how chemicals disrupt the brain's structure and function. Neurotoxins, which can be found in environmental pollutants, pharmaceuticals, and occupational settings, pose significant risks to both acute and chronic neurological health. Conditions such as peripheral neuropathy, cognitive decline, and movement disorders can result from exposure to these toxins. Understanding the pathways through which neurotoxins exert their effects—such as through oxidative stress, inflammation, and mitochondrial dysfunction—has become a critical area of research. Additionally, advances in toxicology are leading to improved risk assessments, better safety protocols, and therapeutic interventions that can mitigate the damage caused by neurotoxic substances.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Toru Kondo
Hokkaido University, Japan
Isao Okunishi
Kinjirushi Co., Ltd, Japan
Thomas J Webster
Brown University, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Spring break: A true story of hope and determination
Steven Benvenisti, Davis, Saperstein Salomon, PC, United States
Title : The role of compromised cerebrospinal fluid circulation in sleep apnea
Joe Sam Robinson, Mercer University, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Nervous system effects in chemicals with immediately dangerous to life or health values
Sudha P Pandalai, National Institute for Occupational Safety and Health, United States
Title : Clinical outcomes of AI-augmented cognitive rehabilitation in dementia and mild cognitive impairment
Esra Al, NewDays, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States